Sam Klempner, Associate Professor at Harvard Medical School, posted on X about recent paper by him as co-author, titled “Anti-KRAS G12C and Anti-EGFR Rechallenge in Chemotherapy-Refractory KRAS G12C–Mutated Colorectal Cancer: A Case Report” published on Journal of Clinical Oncology.
Authors: Linda Morris, Leontios Pappas, Aditya Pandey, Harshabad Singh, Samuel Klempner, Bennett Caughey
“Proof of principle in KRAS G12C in colorectal cancer, analogous to EGFR rechallenge in RAS WT Colon cancer.
Anti-KRAS G12C + Anti-EGFR Rechallenge in Chemotherapy-Refractory KRAS G12C–Mutated Colorectal Cancer.”